Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Right, the shorting fux are tripping over each other and to outbid, while there is genuine buying happening simultaneously.
CDEL is squirming. Having a tough time covering without rocketing up the share price
Volume increasing every day. Looks like next week will have more price increase continuation.
Clearly a lot of covering going on this morning. CDEL back to bid and ask sitting.
Surprised there is so much fear regarding IPIX. Seems a bit irrational. The only rational explanation is if naked shorting was involved. So, riddle me this...
Whatcha gonna do with all them nekkeds?
Pretty soon he will be able to afford to...
They be incorrect.
Good thing they failed.
Massive covering by CDEL already this morning. Looks like the run will begin soon!
Short covering has resumed. Notably, CDEL is bid and ask sitting again.
Fantastic writing. Thanks for your contributions.
I just counted 7 MMs actively playing ball this morning. Can't remember how long it's been since I've seen that.
They would be able to keep it low to cover for long...
Nice! Nearly impossible to grab the absolute minimum.
I'm going to look in my couch again.
Looks like we will easily clear that million.
I'm thinking green by EOD.
Nice to see short covering early this morning. Looks like this week will bring the volume. Next week will start the RISE.
Nice to note no increase to share count!
This thing is going to be berserk soon
Two upcoming events!!
BOOM!
LOL, exactly.
100% enrollment sent on June 3rd, 6:59 am, so it was achieved June 2 or earlier. If I use June 2nd, then 29 days is....
Tomorrow.
So, I think there is an argument to be made that since the primary and 10 out of 11 secondary outcomes are through day 29 or sooner, why hold up looking at the data?
There is no question, IPIX will get more government funding. The only unknowns are when and how much...
Nice to see L2 with so much short covering activity. Bodes well for next week.
The "selling" is controlled. Make no mistake, there's lot of shares being covered through the artificial transactions.
Hedge fund assets aren't big enough to take on Uncle Sam. They know the end game is near.
There will be no other drug candidate that has the possibility of protecting our populace from bacteria, viruses, fungus and more.
We just need one glob to be transformational.
They wouldn't have submitted a presentation, nor would they have been selected if the content wasn't good.
$1,000 per dose
5 doses per course of treatment
$5,000
1,000,000 times $5,000 = 5 Billion
We are going to get two presentations that showcase how diverse and powerful B is a targeting whole families of viruses. Once we get phase 2 data, I can't imagine the US government not stockpiling a million doses as a matter of national defense.
Selling now is insanity.
Some more of my shares rolled over into long term capital gain territory. No longs are crazy enough to sell here.
I agree. Something's cooking. It's way to quiet. Tick Tock indeed.
Nice to see more covering today. We could be a few short days away from the continuous rise.
Nice to see more short covering today. We are probably just a few days from the daily rise.
Nice to see CDEL covering. bid and ask sitting.
Fantastic news! Tick Tock
Just want to point out that the primary and 10 out of 11 secondary endpoints end at day 29:
Primary Outcome Measures :
Time to sustained recovery through Day 29 [ Time Frame: Day 1 through Day 29 ]
Day of recovery is defined as the first day on which the subject satisfies one of the following three categories from the ordinal scale with response sustained through Day 29:
Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care (other than for per protocol dosing or assessments, as appropriate);
Not hospitalized, limitation on activities and/or requiring home oxygen;
Not hospitalized, no limitations on activities.
Secondary Outcome Measures :
Proportion of subjects achieving recovery status scores at Day 29 [ Time Frame: Day 29 ]
Recovery status scores are the following three categories from the ordinal scale:
Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care (other than for per protocol dosing or assessments, as appropriate);
Not hospitalized, limitation on activities and/or requiring home oxygen;
Not hospitalized, no limitations on activities.
Proportion of subjects that die or develop respiratory failure by Day 29 [ Time Frame: Day 1 through Day 29 ]
Composite endpoint, defined as: Death OR Respiratory failure (requires invasive mechanical ventilation)
Subject Clinical status [ Time Frame: Day 1 through Day 29 ]
Clinical status is measured with an 8-point ordinal scale:
Death
Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO)
Hospitalized, on non-invasive ventilation or high flow oxygen devices
Hospitalized, requiring low-flow supplemental oxygen
Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise)
Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care (other than for per protocol dosing or assessments, as appropriate)
Not hospitalized, limitation on activities and/or requiring home oxygen
Not hospitalized, no limitations on activities
Proportion of subjects achieving at least one category improvement in clinical status [ Time Frame: Day 8, Day 15, Day 29 ]
Proportion of subjects achieving at least two category improvement in clinical status [ Time Frame: Day 8, Day 15, Day 29 ]
Time to at least one category improvement in clinical status [ Time Frame: Day 1 through Day 29 ]
Time to at least two category improvement in clinical status [ Time Frame: Day 1 through Day 29 ]
Time to a National Early Warning Score 2 (NEWS2) of </= 2 and maintained for 24 hours [ Time Frame: Day 1 through Day 29 ]
The NEWS2 score is based on seven clinical parameters (respiration rate, oxygen saturation, any supplemental oxygen, systolic blood pressure, pulse, level of consciousness, temperature)
Change from baseline in National Early Warning Score 2 (NEWS2) [ Time Frame: Day 1 through Day 29 ]
Incidence of treatment-emergent adverse events [ Time Frame: Day 1 through Day 60 ]
Treatment-emergent Adverse Events (TEAEs) have onset dates on or after the study treatment start date
Incidence of treatment-emergent graded laboratory abnormalities [ Time Frame: Day 1 through Day 29 ]
Treatment-emergent abnormalities have onset dates on or after the study treatment start date
Nice to have two future presentations listed. We are already up to 3 total known events for July and August with more to come ...
Petemantx, I note that in the article it speaks to several items:
1) Moscow strain (if true we may have tested B against it)
2) Large spike in cases in Russia, which would put pressure on a treatment
3) Talk about Russia approving Sputnik before it was as thoroughly tested as vaccines in the US
These add up to me that we might get early approval in Russia shortly after top line data.
Imagine we could literally be 2 months away from REVENUE.
I wonder if Russia with give B EUA...?
Moscow variant
Good, I hope it stays that way.
I do have to admit I'm a little scared...
Not sure what the capital gains tax will be for my IPIX fortune
Nope. They are one in the same.